Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Accumulated Depreciation (2020 - 2025)

BioAtla's Accumulated Depreciation history spans 6 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation fell 24.2% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, down 24.2%, while the annual FY2025 figure was $5.3 million, 24.2% down from the prior year.
  • Accumulated Depreciation reached $5.3 million in Q4 2025 per BCAB's latest filing, down from $7.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation ranged from a high of $7.4 million in Q3 2025 to a low of $3.4 million in Q1 2021.
  • Average Accumulated Depreciation over 5 years is $5.6 million, with a median of $5.8 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation: surged 38.66% in 2021, then dropped 24.2% in 2025.
  • A 5-year view of Accumulated Depreciation shows it stood at $4.3 million in 2021, then grew by 26.0% to $5.4 million in 2022, then increased by 13.31% to $6.1 million in 2023, then increased by 15.22% to $7.0 million in 2024, then decreased by 24.2% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Accumulated Depreciation are $5.3 million (Q4 2025), $7.4 million (Q3 2025), and $7.3 million (Q2 2025).